Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2013 Market Report by IndustryMonitor.co

Albany, NY, February 25, 2013 --(PR.com)-- This is the latest and most up-to-date Market Report from Select Biosciences addressing the CTC and CSCmarkets as they are evolving. In this report, they focus upon technical and business trends in these spaces as they are fast evolving.

CTCs have been shown to have prognostic value in a number of cancer types and therefore there is extensive research and development activity to develop methodologies for CTC enumeration as well as analysis. Furthermore, there is a lot of clinical trial activity in a number of different cancer classes seeking to establish the clinical utility of CTC measurements in various cancer subtypes.

To Buy The Copy Of This Report Visit: http://www.industrymonitor.co/report/157625-circulating

Select Biosciences has performed worldwide market tracking wherein analyzed research trends in the study of CTCs and CSCs. Qualitative and quantitative analysis of product vendors and their market penetrance, markers utilized for the capture/study of CTCs and CSCs as well as cancer classes wherein there is current research activity vis-à-vis CTCs and CSCs are described in this dataset derived from worldwide pools of researchers in November and December 2012—therefore these data reflect the current market landscape.

Select Biosciences has also performed extensive analysis of the various clinical trials where CTCs are being enumerated and analyzed. These clinical data set the trajectory of the clinical utility of CTCs.

This data-driven characterization of the CTCs and CSCslandscape is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development—all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling “drag-and-drop” into business presentations/business plans—this Market Report is written and delivered to customers in Microsoft PowerPoint format.

Extensive Technical andMarket Analyses
Presented in this Report

To Request The Sample Visit: http://www.industrymonitor.co/sample/sample/157625

Molecular Characterization of CTCs and CSCs

Technologies for Studying CTCs

CTC Analysis Workflow
Enrichment and Analysis Methodologies
Details of Selected Approaches for CTC Enumeration and Analysis
Name of Company/Institution
Microfluidics-based Approaches
Imaging-based Approaches

CTC and CSC Research Market Landscape

Bottom-up Market Survey Data: Qualitative and Quantitative Market Analysis
Product Vendors and their Penetrance into the Research Market
Methodologies for Studying CTCs and CSCs
Markers for Characterizing CTCs and CSCs

Downstream Analyses on Captured CTCs

CTC Quantitative Market Metrics

Revenues from Clinical Utilization—Market Size, Market Forecast, Growth Rate

Analysis of Clinical Utility of CTCs

Evidence for Biomarker Utility of CTCs
CTC and CSC Clinical Trials Analysis

For More Information Contact:
Hemendra Parmar
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
sales@industrymonitor.co
website: http://www.industrymonitor.co/
Blog: http://industrymonitorblog.blogspot.com/